Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions?
Standard
Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? / Heil, Joerg; Bühler, Anne; Golatta, Michael; Rom, Joachim; Harcos, Aba; Schipp, Anne; Rauch, Geraldine; Junkermann, Hans; Sohn, Christof.
in: ANN SURG ONCOL, Jahrgang 18, Nr. 8, 08.2011, S. 2143-2149.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions?
AU - Heil, Joerg
AU - Bühler, Anne
AU - Golatta, Michael
AU - Rom, Joachim
AU - Harcos, Aba
AU - Schipp, Anne
AU - Rauch, Geraldine
AU - Junkermann, Hans
AU - Sohn, Christof
PY - 2011/8
Y1 - 2011/8
N2 - BACKGROUND: We evaluated whether a supplementary preoperative breast MRI in patients with invasive lobular breast cancer (ILC) has changed number and methods of primary and number of secondary surgical interventions.MATERIALS AND METHODS: This was a retrospective controlled single-center analysis of 178 ILC patients. The 2 study groups consisted of 92 patients with breast MRI (MRI group) and of 86 patients without breast MRI (non-MRI group). We investigated the primary and final surgical procedures and factors that influenced the number of secondary surgical interventions.RESULTS: A total of 40 primary mastectomies (38%) have been performed in the MRI group, compared with 27 (30%) in the non-MRI group (P = .119).There have been more bilateral surgical interventions in the MRI group (14 vs 3 patients; P = .002). The 2 groups did not differ with respect to secondary surgery rates (P = .429). The MRI and non-MRI group were significantly different with respect to age and breast density (P = .003 and P = .002). Yet, both variables seemed not to influence secondary surgery rates (P = .516 and P = .788, respectively).CONCLUSIONS: The implementation of preoperative breast MRI tended to result in more primary mastectomies and bilateral surgeries and did not seem to decrease the secondary surgery rate.
AB - BACKGROUND: We evaluated whether a supplementary preoperative breast MRI in patients with invasive lobular breast cancer (ILC) has changed number and methods of primary and number of secondary surgical interventions.MATERIALS AND METHODS: This was a retrospective controlled single-center analysis of 178 ILC patients. The 2 study groups consisted of 92 patients with breast MRI (MRI group) and of 86 patients without breast MRI (non-MRI group). We investigated the primary and final surgical procedures and factors that influenced the number of secondary surgical interventions.RESULTS: A total of 40 primary mastectomies (38%) have been performed in the MRI group, compared with 27 (30%) in the non-MRI group (P = .119).There have been more bilateral surgical interventions in the MRI group (14 vs 3 patients; P = .002). The 2 groups did not differ with respect to secondary surgery rates (P = .429). The MRI and non-MRI group were significantly different with respect to age and breast density (P = .003 and P = .002). Yet, both variables seemed not to influence secondary surgery rates (P = .516 and P = .788, respectively).CONCLUSIONS: The implementation of preoperative breast MRI tended to result in more primary mastectomies and bilateral surgeries and did not seem to decrease the secondary surgery rate.
KW - Breast Neoplasms
KW - Carcinoma, Ductal, Breast
KW - Carcinoma, Lobular
KW - Cohort Studies
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Magnetic Resonance Imaging
KW - Mammography
KW - Middle Aged
KW - Neoplasm Invasiveness
KW - Preoperative Care
KW - Reoperation
KW - Survival Rate
KW - Treatment Outcome
KW - Clinical Trial
KW - Journal Article
U2 - 10.1245/s10434-011-1565-y
DO - 10.1245/s10434-011-1565-y
M3 - SCORING: Journal article
C2 - 21290193
VL - 18
SP - 2143
EP - 2149
JO - ANN SURG ONCOL
JF - ANN SURG ONCOL
SN - 1068-9265
IS - 8
ER -